Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) study
- 30 June 1995
- journal article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 48 (6) , 757-765
- https://doi.org/10.1016/0895-4356(94)00191-r
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Relation of fibronogen to presence and severity of coronary artery disease is independent of other coexisting heart diseaseAmerican Heart Journal, 1993
- Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)The American Journal of Cardiology, 1993
- ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiographyEuropean Heart Journal, 1993
- Genetic factors determining thrombosis and fibrinolysisAnnals of Epidemiology, 1992
- Thrombosis and cardiovascular diseaseAnnals of Epidemiology, 1992
- Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experienceAmerican Heart Journal, 1990
- GENETIC AND CULTURAL INHERITANCE OF PLASMA FIBRINOGEN CONCENTRATIONThe Lancet, 1987
- Fibrinogen and risk of cardiovascular disease. The Framingham StudyJAMA, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984